Trial intelligence / Profile preview

PK/PD Model of Intravenous Oxytocin Analgesia

NCT05929339Phase 2Completed

Sponsor
Wake Forest University Health Sciences
Start
Aug 2023
Primary completion
Oct 2024
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of oxytocin in pain, sponsored by Wake Forest University Health Sciences. Started Aug 2023; status: completed.

02

Drugs

oxytocin
03

Conditions

pain

Beyond the preview

Go deeper on NCT05929339.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05929339.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call